Asterias Biotherapeutics, Inc.; Inc.;Asterias Biotherapeutics;The Regents of the University of California
发明人:
Wirth III, Edward D.,Carmichael, Stanley T.,Lorenzo Llorente, Irene,Manley, Nathan C.
申请号:
AU2016308555
公开号:
AU2016308555A1
申请日:
2016.08.15
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
In various embodiments methods and compositions for improving a recovery of a subject after a cerebral ischemic injury, such as white matter stroke are provided. In various embodiments, the methods involve administering stem cell-derived oligodendrocyte progenitor cells into or directly adjacent to the infarct core in the brain of the subject.